Promoveo Health

promoveohealth.com

Promoveo Health is a contract sales and marketing solutions company that does most of its work in the pharmaceutical, dental and medical device industries. We are also called a contract sales company but don't let the word "contract"​ lead you to believe that the representatives are 1099 as they are not - all of the representatives that work for Promoveo Health are W2 employees.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

ICON SELECTED BY BARDA TO CONDUCT ANTHRAX VACCINE CLINICAL TRIAL

ICON plc | October 07, 2022

news image

ICON plc. a world-leading healthcare intelligence and clinical research organisation, announces that it has been selected by the US Biomedical Advanced Research and Development Authority part of the Administration for Strategic Preparedness and Response in the Department of Health and Human Services to execute an anthrax vaccine clinical trial. BARDA is providing funding to the Government and Public Health Solutions team at ICON to develop and execute a clinical trial that will ev...

Read More

Business Insights

NEW INTERACTIVE APP FROM RXPERIUS SET TO PROVIDE PHARMA INDUSTRY WITH VITAL PATIENT EXPERIENCE INSIGHTS

rXperius | February 16, 2022

news image

Patients can now provide pharmaceutical manufacturers with real-time feedback on prescription medicines they are taking following the launch of a new app by rXperius, a Raleigh, NC-based company that specializes in the design of innovative technology platforms. The MedXer app, which can be downloaded from the Apple and Google app stores, is the first prescription survey app that allows patients to give feedback on their medications in real time, and over time. MedXer pays patients...

Read More

Pharmacy Market

LIDDS NEXT STEP WITH NANOZOLID® FORMULATED DOCETAXEL

LIDDS AB | February 22, 2022

news image

LIDDS AB announced that the next step in the development of NanoZolid®-formulated docetaxel will be to conduct a short clinical study to understand the immunological effects observed in the Phase I clinical study NZ-DTX-001. In the NZ DTX-001 study, activation of systemic inflammatory biomarkers was observed, which can provide improved conditions for treatment with so-called checkpoint inhibitors and result in treatment effect in non-injected tumors. In the clinical phase I st...

Read More

TETRA BIO-PHARMA ENGAGES ALPHA BRONZE LLC AS INVESTOR RELATIONS AND PUBLIC RELATIONS FIRM

Send Press Releases with GlobeNewswire | March 06, 2020

news image

Tetra Bio-Pharma Inc a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has engaged Alpha Bronze LLC., by its principal, Mr. Pascal Nigen, an investor relations, management consulting and financial communications firm to implement and execute a comprehensive investor relations and communications program. “I am very pleased and excited to have engaged Alpha Bronze as our new IR firm. They have demonstrated in a recent mandate provided to them that...

Read More
news image

Pharmacy Market

ICON SELECTED BY BARDA TO CONDUCT ANTHRAX VACCINE CLINICAL TRIAL

ICON plc | October 07, 2022

ICON plc. a world-leading healthcare intelligence and clinical research organisation, announces that it has been selected by the US Biomedical Advanced Research and Development Authority part of the Administration for Strategic Preparedness and Response in the Department of Health and Human Services to execute an anthrax vaccine clinical trial. BARDA is providing funding to the Government and Public Health Solutions team at ICON to develop and execute a clinical trial that will ev...

Read More
news image

Business Insights

NEW INTERACTIVE APP FROM RXPERIUS SET TO PROVIDE PHARMA INDUSTRY WITH VITAL PATIENT EXPERIENCE INSIGHTS

rXperius | February 16, 2022

Patients can now provide pharmaceutical manufacturers with real-time feedback on prescription medicines they are taking following the launch of a new app by rXperius, a Raleigh, NC-based company that specializes in the design of innovative technology platforms. The MedXer app, which can be downloaded from the Apple and Google app stores, is the first prescription survey app that allows patients to give feedback on their medications in real time, and over time. MedXer pays patients...

Read More
news image

Pharmacy Market

LIDDS NEXT STEP WITH NANOZOLID® FORMULATED DOCETAXEL

LIDDS AB | February 22, 2022

LIDDS AB announced that the next step in the development of NanoZolid®-formulated docetaxel will be to conduct a short clinical study to understand the immunological effects observed in the Phase I clinical study NZ-DTX-001. In the NZ DTX-001 study, activation of systemic inflammatory biomarkers was observed, which can provide improved conditions for treatment with so-called checkpoint inhibitors and result in treatment effect in non-injected tumors. In the clinical phase I st...

Read More
news image

TETRA BIO-PHARMA ENGAGES ALPHA BRONZE LLC AS INVESTOR RELATIONS AND PUBLIC RELATIONS FIRM

Send Press Releases with GlobeNewswire | March 06, 2020

Tetra Bio-Pharma Inc a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has engaged Alpha Bronze LLC., by its principal, Mr. Pascal Nigen, an investor relations, management consulting and financial communications firm to implement and execute a comprehensive investor relations and communications program. “I am very pleased and excited to have engaged Alpha Bronze as our new IR firm. They have demonstrated in a recent mandate provided to them that...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us